Obsidian Therapeutics Appoints Maria Fardis, Ph.D., as Chair of its Board of Directors

January 19, 2022

Read More

Obsidian Therapeutics Appoints Lee Giguere, J.D., as Chief Legal Officer and Corporate Secretary

December 7, 2021

Read More

Obsidian Therapeutics Appoints Heidi Hagen to Board of Directors

November 16, 2021

Read More

We are pioneers in cell and gene therapy

Leading the next generation of engineered therapeutics

Read More

Our Platform

Our proprietary
cytoDRiVE platform

Leverages drug responsive domains (DRDs) to control protein function using an FDA-approved small molecule

Read More


Join Our Team

Join our collaborative team of innovators who are motivated by a sense of urgency to help patients in need.
Our collective knowledge, capabilities, intellect and energy is our greatest strength.


Read More